TONIX PHARMACEUTICALS HOLDING CORP. Operating Leases, Future Minimum Payments, Due in Three Years
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Operating Leases, Future Minimum Payments, Due in Three Years of $6.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-05-13
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $6.00K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $212.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $187.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $181.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2019-03-31 | $6.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $212.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $187.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $181.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $181.00K 10-Q · filed 2018-05-11 |
| 2017-09-30 | $181.00K 10-K · filed 2018-03-09 |
| 2017-06-30 | $181.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $181.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $181.00K 10-K · filed 2017-04-13 |
| 2016-09-30 | $607.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $607.00K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $607.00K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $607.00K 10-K · filed 2016-03-03 |
| 2015-09-30 | $683.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $569.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $459.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $459.30K 10-K · filed 2015-02-27 |
| 2014-09-30 | $445.89K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $445.89K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $277.51K 10-Q · filed 2014-05-13 |
| 2012-12-31 | $100.72K 10-K/A · filed 2013-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |